Current advances in transfusion medicine 2021: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee

Background Each year the AABB Clinical Transfusion Medicine Committee (CTMC) procures a synopsis highlighting new, important, and clinically relevant studies in the field of transfusion medicine (TM). This has been made available as a publication in Transfusion since 2018. Methods CTMC members reviewed and identified original manuscripts covering TM-related topics published electronically (ahead-of-print) or in print from December 2020 to December 2021. Selection of publications was discussed at committee meetings and chosen based on perceived relevance and originality. Next, committee members worked in pairs to create a synopsis of each topic, which was then reviewed by additional committee members. The first and senior authors assembled the final manuscript. Although this synopsis is extensive, it is not exhaustive, and some articles may have been excluded or missed. Results The following topics are included: blood products; convalescent plasma; donor collections and testing; hemoglobinopathies; immunohematology and genomics; hemostasis; patient blood management; pediatrics; therapeutic apheresis; and cell therapy. Conclusions This synopsis highlights and summarizes recent key developments in TM and may be useful for educational purposes.

Automated summary

This article presents an annual synopsis of the AABB Clinical Transfusion Medicine Committee (CTMC) in the field of transfusion medicine. It includes topics such as blood products, convalescent plasma, donor collections and testing, hemoglobinopathies, immunohematology and genomics, hemostasis, patient blood management, pediatrics, therapeutic apheresis, and cell therapy. The synopsis provides a useful resource for educational purposes.